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Summary
 Background HDR brachytherapy has been employed in the treatment of cancers in numerous 
locations around the body, however, few publications have dealt with primary carci-
nomas of the head and neck. To our knowledge, only one paper concerns the use 
of this technique in the treatment of cancers of the lower lip. Furthermore, the rec-
ommendations given by the American Association of Brachytherapy do not appear 
to elaborate on the subject.
 Aim To analyse the treatment of lower lip carcinoma by interstitial HDR brachytherapy.
 Materials/Methods Retrospective analysis of the results of treatment was carried out among a group 
of 24 consecutive patients, of whom 18 were treated by brachytherapy alone while 
6 others were treated after surgery. Fifteen patients were classifi ed as T1, nine 
patients as T2. 23 patients were classifi ed as N0 and one as N1. Each patient had 
histologically confi rmed squamous cell carcinoma. Radiotherapy involved inter-
stitial, high dose rate brachytherapy with an iridium-192 source. Post-operative 
brachytherapy was indicated in cases of microscopically incomplete excision. The 
dose was determined using the Paris method, the reference dose being 80% or 
at a point 3–5 mm from the macroscopic lesion or tumour bed. The mean total 
dose was 35 Gy, the mean number of fractions was 7, and the mean fraction dose 
was 5.7 Gy. The total treatment time was 12 days, on average, whereas the mean 
follow-up was 32 months.
 Results Local control was obtained after 24 months in 21 patients (87.5%). All patients devel-
oped a severe early reaction. Three patients with mouth corner infi ltration (100%) 
failed to show complete regression. Two of these patients underwent additional ir-
radiation to the residual lesion, resulting in cures. The third patient underwent suc-
cessful surgical treatment. The cosmetic and functional effect was very good.
 Conclusuions Interstitial HDR brachytherapy is an effective and safe method for the treatment 
of carcinoma in the lower lip.
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BACKGROUND
HDR brachytherapy has been employed in the 
treatment of cancers in numerous locations around 
the body, however, few publications have dealt with 
primary carcinomas of the head and neck. To our 
knowledge, only one paper concerns the use of this 
technique in the treatment of cancers of the lower 
lip [1]. Furthermore, the recommendations giv-
en by the American Association of Brachytherapy 
do not appear to elaborate on the subject [2]. As 
the parameters for radiation therapy of squamous 
carcinomas of the lower lip have not been well-de-
fi ned, we present the results of studies dedicated 
to the elucidation of this problem.
MATERIALS AND METHODS
In a retrospective study, we investigated the re-
sults of treatment in 24 consecutive cases, wherein 
patients underwent defi nitive treatment between 
January 1998 and December 2000. Exclusive 
brachytherapy was administered to 18 patients 
and the remaining 6 were treated after previous 
non-radical surgery. Fifteen patients were classi-
fi ed as T1 and nine as T2. 23 patients were classi-
fi ed as N0 and one as N1 (Figure 1). The corner 
of the mouth was infi ltrated in three patients. The 
mean lesion dimensions were 1.7 cm (±1.1 cm) 
X 1.2 cm (± 0.8 cm). Each patient had histolog-
ically confi rmed squamous cell carcinoma. G3, 
G2 and G1 were found in 10, 5 and 9 patients, 
respectively. The average age of the patients was 
65 years, ranging between 43 and 83 years. Of the 
24 patients, 4 were women (16%) and 20 were 
men (84%). One patient also suffered from lung 
cancer while two had previous cancers of the lar-
ynx. One patient had suffered a cerebral stroke. 
According to recommendations, post-operative 
brachytherapy was indicated in the cases of micro-
scopic non-radical surgical treatment, or where 
information was lacking regarding the features 
of the margin (three patients out of 6).
Radiation treatment involved interstitial, high 
dose rate brachytherapy with the use of an irid-
ium-192 source. The dose was determined by the 
Paris method, the reference dose being 80% or 
at points 3–5 mm from the macroscopic lesion 
or tumour bed. Implantation was carried out un-
der local anaesthesia (1% ligocaine along the 
predicted paths of the interstitial needles). The 
mean total dose was 35 Gy (range: 15–51 Gy), the 
mean number of fractions was 7 (range: 1–15), 
the mean fractional dose was 5.7 Gy (range: 3–15 
Gy). The average number of needles was 2 (range: 
1–5) (Figure 2). The duration of fractions did not 
exceed 3 minutes and was dependent on the vol-
ume of the implant, the number of needles and 
the activity of the source. Total treatment time 
was, on average, 12 days (range: 1–40 days) and 
the mean and median follow-up periods were 32 
and 35 months respectively.
Local control was defi ned as being no evidence 
of the disease at 24 months and was the clinical 
end-point of our study.
RESULTS
Complete remission was achieved by the 24th 
month in 23 patients. In all cases, a severe acute 
reaction was observed, which initially manifest-
ed itself as erythema followed by epitheliolysis 
around the lesion (Figure 3). Similarly, the pri-
mary tumour was desquamated within 2–3 weeks 
after the completion of the treatment. Infi ltration 
of the corner of the mouth involves the risk of top-
ographical errors, observed in all three patients 
with this condition. A complete response was not 
achieved in two cases. The dose to the residual le-
sion in these cases was increased and control was 
obtained (Figure 4). The decision to apply addi-
tional irradiation was usually taken three weeks 
after the healing of severe reactions (regression 
of epitheliolysis) and involved the administration 
of a dose of 12 Gy in four fractions, carried out 
in the 4th week, leading to complete remission. 
The third patient was effectively treated surgical-
ly, with no serious late complications.
Late effects such as fi brosis, skin retraction, hypo- 
and hyper-pigmentation and ulceration were not 
observed. The cosmetic and functional results 
were very good (Figure 5). The only cosmetic de-
fects were the loss of a small degree of tissue at 
the point of primary infi ltration and telangiecta-
sia, which developed in two patients. There were 
no complications, such as bleeding or infection, 
associated with implantation (Figure 6).
DISCUSSION
Lower lip carcinomas are effectively treated by 
surgery and irradiation. Treatment results, in the 
early stages of lower lip cancer, are good. More 
than 90% of cases achieve 3-year local control. 
However, the results are less satisfactory (23%) 
in cases of mandibular infi ltration [3,4]. The re-
sults of brachytherapy treatment, primarily con-
cerning the LDR method, have not been exten-
sively published. Beauvois [5] reviewed a group 
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of 237 patients, treated with the LDR technique 
in the period 1972–1991, in which local control 
was achieved in 95% of cases at 5 years and, by 
applying salvage surgery, this fi gure has now ris-
en to as much as 99% of all cancer patients. The 
risk of late complications depended on the size 
(thickness) of the area under treatment, the crit-
ical dimension being 1.4 cm. Tombolini [6] de-
scribed a group of 57 patients in whom local con-
trol was achieved in 90% of cases at 3-years (up 
to 94% with salvage surgery) with very good func-
tional and cosmetic effects. Similarly, Orecchia 
Figure 1. A typical T1N0M0 patient with squamous cancer of 
the lower lip.
Figure 2. The plane of interstitial implants.
Figure 3. Control of the proper implant geometry between 
fractions (day 8).
Figure 4. Extensive epitheliolysis of a tumour 14 days after the 
completion of treatment.
Figure 5. The implant covering the remaining inﬁ ltrate in the 
area below the corner of the mouth, the tumour pole above the 
corner has disappeared.
Figure 6. Eﬀ ect of treatment after 24 months. Only a small loss 
of tissue at the primary tumour site is observed. No telangiectasia 
or ﬁ brosis is detected.
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[7] reported 93% local control in a group of 47 
patients, and effective salvage surgery in two out 
of three failures. He also achieved an excellent 
cosmetic effect in 91% of all cases.
We have found only one paper reporting the in-
terstitial HDR technique. The study, by Guinot 
[1], comprised a group of 39 patients, including 
4 cases treated by previous surgery. He achieved 
88% local control after 3-years in this group (21/
21, 5/6 and 9/12 patients classifi ed into disease 
stages of T1,T2, and T4, respectively). The follow-
ing treatment plans were employed: 5.5 Gy × 8 
fractions, 5.3 Gy × 8 fractions and 4.5 Gy × 10 BID 
fractions. These treatment plans were different 
from those used in our department. We did not 
treat patients with T3 or T4 tumours. We started 
our therapy with a plan of 6×6 Gy and weekly in-
tervals. Very good tolerance of acute reactions 
permitted a reduction of the total treatment time. 
Also, in order to neutralize the potential threat 
of late complications, we lowered the fractional 
dose to 3 Gy, while at the same time increasing 
the total dose to 51 Gy, thereby compensating for 
the loss of radiobiologial effectiveness. Doses were 
administered once, twice or three times daily as 
necessary, so as to maintain the minimum 6-hour 
interval between the fractions over two weeks. As 
a rule, implants were applied two or three times, 
which, in our opinion, reduced the risk of under-
estimation of the dose. Guinot applied the im-
plant only once and used, on average, three nee-
dles (maximum 9 needles), making it possible to 
employ a 90% reference isodose. In our case, an 
average of 2 needles and an 80% reference isod-
ose were used (Figure 7). We observed infl amma-
tion of the mucous membranes, and ulceration, 
in all of our patients, but this was cured in a max-
imum of two months. No active bleeding or infec-
tions were noted. The implant did not affect the 
proper functioning of the lip or mouth.
CONCLUSIONS
1. Interstitial HDR brachytherapy is a safe and ef-
fective method for the treatment of carcinomas 
of the lower lip.
2. Mouth corner infi ltration does not lend itself 
to interstitial treatment.
Figure 7. Coronal, sagittal and horizontal planes of isodose distribution for two needle implants.
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